{{Rsnum
|rsid=1805054
|Gene=HTR6
|Chromosome=1
|position=19666020
|Orientation=plus
|GMAF=0.1722
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=HTR6
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 74.3 | 25.7 | 0.0
| HCB | 56.9 | 35.8 | 7.3
| JPT | 47.3 | 41.1 | 11.6
| YRI | 69.0 | 27.6 | 3.4
| ASW | 61.4 | 31.6 | 7.0
| CHB | 56.9 | 35.8 | 7.3
| CHD | 62.4 | 36.7 | 0.9
| GIH | 70.3 | 27.7 | 2.0
| LWK | 74.5 | 21.8 | 3.6
| MEX | 77.2 | 22.8 | 0.0
| MKK | 71.2 | 25.6 | 3.2
| TSI | 75.5 | 21.6 | 2.9
| HapMapRevision=28
}}
also known as C267T
{{PMID Auto
|PMID=19590397
|Title=5-HTR1A, 5-HTR2A, 5-HTR6, TPH1 and TPH2 polymorphisms and major depression
}}

{{PMID Auto
|PMID=20394784
|Title=Serotonin 6 receptor gene and mood disorders: case-control study and meta-analysis.
}}

{{PMID Auto
|PMID=20705401
|Title=Serotonin 6 receptor gene is associated with methamphetamine-induced psychosis in a Japanese population.
}}

{{PMID Auto
|PMID=21162693
|Title=Pharmacogenetics and antipsychotics: therapeutic efficacy and side effects prediction.
|OA=1
}}

{{PMID Auto
|PMID=21172166
|Title=Pharmacogenetics of antidepressant response.
|OA=1
}}

{{PMID Auto
|PMID=23733030
|Title=Pharmacogenetics in major depression: a comprehensive meta-analysis.
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}